Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 15/20 | 0.59 |
| ▸ | DDB1 | Q16531 | 11/20 | 0.59 |
| ▸ | TNF | P01375 | 1/20 | 0.59 |
| ▸ | IL1B | P01584 | 1/20 | 0.59 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.59 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.37 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18900418 | 0.91 | CRBN (0.61) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL283199 | 0.91 | CRBN (0.61) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL26320556 | 0.91 | CRBN (0.63) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL26320519 | 0.90 | CRBN (0.62) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL26324033 | 0.90 | CRBN (0.62) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL26320535 | 0.90 | CRBN (0.62) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL26320573 | 0.90 | CRBN (0.62) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL328600 | 0.88 | CRBN (0.59) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL28617990 | 0.88 | CRBN (0.62) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL31316579 | 0.88 | CRBN (0.63) | CRBNDDB1TNFIL1BIKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9119854-B2 | Methods for treating cancer using combination therapy | CELGENE CORPORATION (US) | 2015-09-01 | — | — | US | disclosed |